注射用益气复脉(冻干)治疗慢性心力衰竭的预算影响分析
|
摘要
目的为药品报销目录的遴选决策、药品降价谈判及确立医保支付价格提供借鉴和参考。方法基于预算影响分析模型,查阅文献、统计年鉴、CFDA南方医药经研究所的重点城市公立医院中成药与化学药终端监测分析系统(简称HDM系统),以及天津天士力之骄药业有限公司提供的益气复脉2013~2016年销售额等数据,比较分析了目前市场上用于治疗慢性心力衰竭的主要中药注射剂的市场组成,并预测未来五年内(2017~2021年)益气复脉未纳入医保目录与益气复脉纳入医保目录两种情形下医保基金总支出。结果如果2017年益气复脉纳入国家医保目录,价格适度调整后,预计未来五年医保基金结余将逐年递增,累计结余约2亿元。结论预计注射用益气复脉(冻干)能够为医保节约开支,建议将注射用益气复脉(冻干)纳入医保目录。
Objective This study provides reference for the selection decision of health insurance catalog medicine,health insurance drug negotiation and the determination of health insurance payment price.Methods Based on the budget impact analysis model, the data of treatment of acute myocardial infarction were analyzed by reviewing the literature,health statistics yearbook,CFDA Southern Medical Research Institute HDM system,and sales data provided by Tianjin Tasly Pride Pharmaceutical Co. Ltd. The market share of the main Chinese medicine injections for the treatment of chronic heart failure were studied to predict the total expenditure of health insurance fund if Yiqifumai is included in the health insurance catalog or if it is not included in the next five years. Results If Yiqifumai injection( lyophilization) is included into the 2017 national health insurance catalog and its price can be moderately adjusted, the health care fund balance will increase year by year within the next five years,and the cumulative balance of health insurance fund will reach 200 million yuan. Conclusion It is expected that Yiqifumai injection( lyophilization) can save budget for health insurance expenditure,and we recommend that it should be included into health insurance catalog.
Objective This study provides reference for the selection decision of health insurance catalog medicine,health insurance drug negotiation and the determination of health insurance payment price.Methods Based on the budget impact analysis model, the data of treatment of acute myocardial infarction were analyzed by reviewing the literature,health statistics yearbook,CFDA Southern Medical Research Institute HDM system,and sales data provided by Tianjin Tasly Pride Pharmaceutical Co. Ltd. The market share of the main Chinese medicine injections for the treatment of chronic heart failure were studied to predict the total expenditure of health insurance fund if Yiqifumai is included in the health insurance catalog or if it is not included in the next five years. Results If Yiqifumai injection( lyophilization) is included into the 2017 national health insurance catalog and its price can be moderately adjusted, the health care fund balance will increase year by year within the next five years,and the cumulative balance of health insurance fund will reach 200 million yuan. Conclusion It is expected that Yiqifumai injection( lyophilization) can save budget for health insurance expenditure,and we recommend that it should be included into health insurance catalog.
引文
[1]毋领娟.慢性心力衰竭中西医结合临床路径实施效果评价[D].郑州:河南中医药大学,2016.
[2]黄峻.中国心力衰竭流行病学特点和防治策略[J].中华心脏与心律电子杂志,2015,3(2):2-3.
[3]李晓阳,杨志欣.注射用益气复脉(冻干)研究概况[J].科学技术创新,2016,11(6):79.
[4]马宁,侯雅竹,王贤良,等.注射用益气复脉(冻干)不良反应文献研究与分析[J].中国新药杂志,2015,14(10):1197-1200.
[5]RABELO E R,ALITI G B,GOLDRAICH L,et al.Non-pharmacological management of patients hospitalized w ith heart failure at a teaching hospital[J].Arq Bras Cardiol,2006,87(3):352-358.
[6]ISPOR T,SULLIVAN S,MAUSKOPF J,et al.Budget impact analysis-principles of good practice:report of the ISPOR 2012 budget impact analysis good practice II task force[J].Value in Health,2014,17:5-14.
[7]陈可冀,吴宗贵,朱明军,等.慢性心力衰竭中西医结合诊疗专家共识[J].心脑血管病防治,2016,16(5):225-232.
[8]李兵.循证护理模式在慢性心力衰竭患者中的应用效果[J].中国循证心血管医学杂志,2016,8(1):60-62.
[9]胡善联.预算影响分析与药物经济学分析[J].中国药房,2004,15(3):158-161.
[2]黄峻.中国心力衰竭流行病学特点和防治策略[J].中华心脏与心律电子杂志,2015,3(2):2-3.
[3]李晓阳,杨志欣.注射用益气复脉(冻干)研究概况[J].科学技术创新,2016,11(6):79.
[4]马宁,侯雅竹,王贤良,等.注射用益气复脉(冻干)不良反应文献研究与分析[J].中国新药杂志,2015,14(10):1197-1200.
[5]RABELO E R,ALITI G B,GOLDRAICH L,et al.Non-pharmacological management of patients hospitalized w ith heart failure at a teaching hospital[J].Arq Bras Cardiol,2006,87(3):352-358.
[6]ISPOR T,SULLIVAN S,MAUSKOPF J,et al.Budget impact analysis-principles of good practice:report of the ISPOR 2012 budget impact analysis good practice II task force[J].Value in Health,2014,17:5-14.
[7]陈可冀,吴宗贵,朱明军,等.慢性心力衰竭中西医结合诊疗专家共识[J].心脑血管病防治,2016,16(5):225-232.
[8]李兵.循证护理模式在慢性心力衰竭患者中的应用效果[J].中国循证心血管医学杂志,2016,8(1):60-62.
[9]胡善联.预算影响分析与药物经济学分析[J].中国药房,2004,15(3):158-161.